Patrik Palacka

11PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 26, 2025
Prognostic Value of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab.

Zuzana Tomčová, Jana Obertová, Michal Chovanec

|Nov 27, 2024
Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma.

Vladimira Durmanova, Iveta Mikolaskova, Eszter Zsemlye

|May 27, 2023
Effect of Vaccination on Platelet Mitochondrial Bioenergy Function of Patients with Post-Acute COVID-19.

Anna Gvozdjáková, Jarmila Kucharská, Zuzana Rausová

|Nov 11, 2022
Changes in CoQ10/Lipids Ratio, Oxidative Stress, and Coenzyme Q10 during First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma (mUC).

Patrik Palacka, Jarmila Kucharská, Jana Obertová

|Oct 27, 2022
Response of the Urothelial Carcinoma Cell Lines to Cisplatin.

Andrea Holíčková, Jan Roška, Eveline Órásová

|Jul 19, 2022
Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab.

Patrik Palacka, Pavol Janega, Hana Polakova

Pageof 2

Frequent Collaborators

3 joint publications

Anna Gvozdjáková

2 joint publications

Zuzana Sumbalová

2 joint publications

Miroslav Chovanec

1 joint publications

Samuel Furka